Showing results (311-320 of 338) with videos related to
Sort By:
Pageof 34
European Neurology|November 30, 2000
Electrophysiological, neuropsychological and clinical findings in multiple sclerosis patients receiving interferon beta-1b: a 1-year follow-upW Gerschlager, R Beisteiner, L Deecke, et al.Neurology|April 1, 1998
Clinical seizure lateralization in mesial temporal lobe epilepsy: differences between patients with unitemporal and bitemporal interictal spikesW Serles, E Pataraia, J Bacher, et al.Der Anaesthesist|January 1, 1989
[Evoked potentials in the follow-up and prognosis of patients with craniocerebral trauma]J Zeitlhofer, M Steiner, E Zadrobilek, et al.Stroke|February 1, 1989
Quantification of regional cerebral blood flow with IMP-SPECT. Reproducibility and clinical relevance of flow valuesI Podreka, C Baumgartner, E Suess, et al.International Psychogeriatrics|April 5, 2017
Semantic memory and depressive symptoms in patients with subjective cognitive decline, mild cognitive impairment, and Alzheimer's diseaseJ Lehrner, G Coutinho, P Mattos, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 1987
Initial experience with technetium-99m HM-PAO brain SPECTI Podreka, E Suess, G Goldenberg, et al.Journal of Neural Transmission. Supplementum|January 1, 1991
Galanthamine treatment in Alzheimer's diseaseP Dal-Bianco, J Maly, C Wôber, et al.Wiener Klinische Wochenschrift|May 29, 1987
[Reversible opening of the blood-brain barrier in the chemotherapy of malignant gliomas]K Heimberger, P Samec, I Podreka, et al.Acta Radiologica. Supplementum|January 1, 1986
Blood brain barrier modification and chemotherapy. Interventional neuroradiology in the treatment of malignant gliomasK Heimberger, P Samec, H Binder, et al.Brain Topography|January 1, 1988
Hexa-methyl-propylene-amine-oxime (HMPAO) single photon emission computed tomography (SPECT) in epilepsyI Podreka, W Lang, E Suess, et al.Pageof 34